|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12Q 1/6886 |
| (11) | Patento numeris | 3169797 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15734713.9 |
| Europos patento paraiškos padavimo data | 2015-07-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-05-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-08-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2015/065986 |
| Data | 2015-07-13 |
| (87) | Numeris | WO 2016/008853 |
| Data | 2016-01-21 |
| (30) | Numeris | Data | Šalis |
| 14176944 | 2014-07-14 | EP |
| (72) |
LEVESQUE, Mitchell Paul, CH
DUMMER, Reinhard, CH
WIDMER, Daniel, CH
RAAIJMAKERS, Marieke Ineke Geertje, CH
|
| (73) |
Universität Zürich Prorektorat MNW,
Rämistrasse 71, 8006 Zürich,
CH
|
| (54) | MEANS AND METHODS FOR IDENTIFYING A PATIENT HAVING A BRAF-POSITIVE CANCER AS A NON-RESPONDER TO A BRAF INHIBITOR AND AS A RESPONDER TO AN MAPK/ERK INHIBITOR |
| MEANS AND METHODS FOR IDENTIFYING A PATIENT HAVING A BRAF-POSITIVE CANCER AS A NON-RESPONDER TO A BRAF INHIBITOR AND AS A RESPONDER TO AN MAPK/ERK INHIBITOR |